| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 10 |
| 1 | HYDROXYCHLOROQUINE | 9 |
| 2 | METHOTREXATE | 9 |
| 3 | RITUXIMAB | 9 |
| 4 | TACROLIMUS | 9 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 9 |
| 6 | TACROLIMUS OINTMENT 0.1% | 9 |
| 7 | ADALIMUMAB | 8 |
| 8 | MYCOPHENOLATE MOFETIL | 8 |
| 9 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METHYLENE BLUE | 1 | 0.0006 |
| 1 | BELATACEPT | 2 | 0.0004 |
| 2 | PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF | 2 | 0.0004 |
| 3 | FLUOROMETHOLONE | 1 | 0.0003 |
| 4 | ALEMTUZUMAB | 5 | 0.0003 |
| 5 | KETOTIFEN FUMARATE | 1 | 0.0002 |
| 6 | HUMAN INSULIN | 1 | 0.0001 |
| 7 | BINIMETINIB | 1 | 0.0001 |
| 8 | FONDAPARINUX SODIUM | 1 | 0.0001 |
| 9 | EVEROLIMUS TABLETS | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 1 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 5 | 0.0003 |
| 3 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 4 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 6 | 0.0001 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 4 | 0.0001 |
| 7 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Aromatase Inhibitor [EPC] | 4 | 0.0000 |